On November 16, 2022 the supporting association of the new cluster initiative Life-Science Saxony-Anhalt was founded in the technology park Weinberg Campus. We, the Heppe Medical Chitosan GmbH, are excited to be part of it as a founding member.

HMC has successfully passed its re-certification to ISO 13485:2016 for the design and development, manufacture and distribution of chitin, chitosan and chitosan derivatives for medical devices. Our current certificate is valid until November 2024. You can get it in our download area.

After a two-year pandemic break, the Accelerator Startup Meetup will take place on June 14, 2022 in the Innovation Hub of the Weinberg Campus. One of the keynote speakers is our CEO Katja Richter. She will give a talk on the topic: ''From research to startup to global market leader for medical chitosans'' at 5:30 pm.

At the EUCHIS (European Chitin Society) webinar on the 26th of october 2021, Katja Richter, CEO of HMC, talked about the use of chitosans in medicine and the different aspects that need to be considered in terms of guidelines, qualities or proper chitosan ordering.

In this article we would like to give you a brief overview of the structure of our Product Specification Sheets and the Certificate of Analysis.

HMC gains its new ISO 13485:2016 certificate for the design and development, manufacture and distribution of chitin, chitosan and chitosan derivatives for medical devices. Our current certificate is valid until November 2024. You can get it in our download area.